Amicus Therapeutics Inc (FOLD)

10:18 AM

Amicus Therapeutics stock hits 52-week high at $14.44 By Investing.com - Investing.com India

10:18 AM

Mar 30, 2026

EPS Watch: Is Amicus Therapeutics Inc in a bullish channelMarket Sentiment Report & Weekly High Return Stock Opportunities - baoquankhu1.vn

Mar 30, 2026

Mar 30, 2026

Amicus Therapeutics (NASDAQ:FOLD) Reaches New 1-Year HighStill a Buy? - MarketBeat

Mar 30, 2026

Mar 29, 2026

Assessing Amicus Therapeutics (FOLD) Valuation After A Strong 71% One Year Total Return - Yahoo Finance

Mar 29, 2026

Mar 29, 2026

210,800 Shares in Amicus Therapeutics, Inc. $FOLD Acquired by CIBRA Capital Ltd - MarketBeat

Mar 29, 2026

Mar 29, 2026

FOLD PE Ratio & Valuation, Is FOLD Overvalued - intellectia.ai

Mar 29, 2026

Mar 26, 2026

Recap Report: What is the long term forecast for Amicus Therapeutics Inc stockQuarterly Market Review & Free Daily Entry Point Trade Alerts - baoquankhu1.vn

Mar 26, 2026

Mar 26, 2026

Vanguard disaggregates holdings, reports 0% in Amicus (NASDAQ: FOLD) - Stock Titan

Mar 26, 2026

Mar 26, 2026

JPMorgan Chase & Co. Sells 94,105 Shares of Amicus Therapeutics, Inc. $FOLD - MarketBeat

Mar 26, 2026

Mar 25, 2026

ETFs investiert in Amicus Therapeutics, Inc.-Aktien - TradingView

Mar 25, 2026

Mar 25, 2026

Morgan Stanley Upgrades Amicus (FOLD) on IP Strength and Pipeline Expansion - MSN

Mar 25, 2026

Mar 23, 2026

Amicus Therapeutics (NASDAQ:FOLD) Hits New 52-Week HighWhat's Next? - MarketBeat

Mar 23, 2026

Mar 21, 2026

Amicus Therapeutics stock hits 52-week high at 14.39 USD By Investing.com - Investing.com Canada

Mar 21, 2026

Mar 20, 2026

Amicus Therapeutics stock hits 52-week high at 14.39 USD - Investing.com

Mar 20, 2026

Mar 20, 2026

Hudson Bay Capital Management LP Cuts Position in Amicus Therapeutics, Inc. $FOLD - MarketBeat

Mar 20, 2026

Mar 19, 2026

Amicus Therapeutics, Inc.(NasdaqGM: FOLD) dropped from NASDAQ Biotechnology Index - marketscreener.com

Mar 19, 2026

Mar 17, 2026

FOLD Should I Buy - Intellectia AI

Mar 17, 2026

Mar 16, 2026

872,411 Shares in Amicus Therapeutics, Inc. $FOLD Acquired by Ion Asset Management Ltd. - MarketBeat

Mar 16, 2026

Mar 16, 2026

Iron Triangle Partners LP Takes Position in Amicus Therapeutics, Inc. $FOLD - MarketBeat

Mar 16, 2026

Mar 16, 2026

BioMarin to acquire rare disease drug developer Amicus for $4.8B - MSN

Mar 16, 2026

Mar 16, 2026

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat

Mar 16, 2026

Mar 15, 2026

Assessing Amicus Therapeutics (FOLD) Valuation After Recent Share Price Momentum And DCF Upside - Yahoo Finance

Mar 15, 2026

Mar 15, 2026

Amicus Therapeutics stock hits 52-week high at 14.38 USD By Investing.com - Investing.com Nigeria

Mar 15, 2026

Mar 15, 2026

Elevation Point Wealth Partners LLC Makes New Investment in Amicus Therapeutics, Inc. $FOLD - MarketBeat

Mar 15, 2026

Mar 15, 2026

Assessing Amicus Therapeutics (FOLD) Valuation After Strong Recent Share Price Momentum - simplywall.st

Mar 15, 2026

Mar 14, 2026

Amicus Therapeutics, Inc. $FOLD Shares Sold by Prosight Management LP - MarketBeat

Mar 14, 2026

Mar 14, 2026

Avoro Capital Advisors LLC Decreases Stock Holdings in Amicus Therapeutics, Inc. $FOLD - MarketBeat

Mar 14, 2026

Mar 12, 2026

Assessing Amicus Therapeutics (FOLD) After Strong One Year Share Price Performance - simplywall.st

Mar 12, 2026

Mar 12, 2026

Amicus Therapeutics stock hits 52-week high at 14.38 USD - Investing.com India

Mar 12, 2026

Mar 11, 2026

Amicus Therapeutics (NASDAQ:FOLD) Reaches New 12-Month HighTime to Buy? - MarketBeat

Mar 11, 2026

Mar 10, 2026

Genomenon and Amicus Therapeutics Partner to Advance Fabry Disease Awareness and Diagnosis - PR Newswire

Mar 10, 2026

Mar 07, 2026

Amicus Therapeutics (FOLD) Announces Approval for Pombiliti + Opfolda by Japan’s Ministry of Health, Labour and Welfare (MHLW) - msn.com

Mar 07, 2026

Mar 07, 2026

Jefferies Downgrades Amicus Therapeutics, Inc. (FOLD) to Buy And Lowers Price Target Amid Takeover Developments - MSN

Mar 07, 2026

Mar 06, 2026

How The Amicus Therapeutics (FOLD) Story Is Shifting Inside BioMarin’s Rare Disease Portfolio - Yahoo Finance

Mar 06, 2026

Mar 05, 2026

Amicus Therapeutics2026 Funding Rounds & List of Investors - Tracxn

Mar 05, 2026

Mar 05, 2026

Amicus Therapeutics Buyout Advances As Valuation Gap Draws Investor Focus - Yahoo Finance

Mar 05, 2026

Mar 04, 2026

Bradley Campbell Sells 22,500 Shares of Amicus Therapeutics (NASDAQ:FOLD) Stock - MarketBeat

Mar 04, 2026

Mar 04, 2026

Insider Sell: Bradley Campbell Sells 22,500 Shares of Amicus The - GuruFocus

Mar 04, 2026

Mar 04, 2026

Amicus Therapeutics (FOLD) CEO Bradley Campbell sells 22,500 shares in open market - Stock Titan

Mar 04, 2026

Mar 04, 2026

FOLD SEC FilingsAmicus Therapeut 10-K, 10-Q, 8-K Forms - Stock Titan

Mar 04, 2026

Mar 04, 2026

FDA’s rare disease toolbox not fully used - BioWorld MedTech

Mar 04, 2026

Mar 04, 2026

JPMorgan Chase & Co. Has $16.68 Million Stock Position in Amicus Therapeutics, Inc. $FOLD - MarketBeat

Mar 04, 2026

Mar 04, 2026

Is It Too Late To Consider Amicus Therapeutics (FOLD) After The Proposed BioMarin Deal Price? - simplywall.st

Mar 04, 2026

Mar 03, 2026

Amicus Therapeutics shareholders approve acquisition by BioMarin Pharmaceutical - Investing.com

Mar 03, 2026

Mar 03, 2026

Amicus Stockholders Approve BioMarin Acquisition at Special Meeting - TipRanks

Mar 03, 2026

Mar 03, 2026

Shareholders back Amicus (NASDAQ: FOLD) sale to BioMarin Pharmaceutical - Stock Titan

Mar 03, 2026

Mar 03, 2026

Amicus Therapeutics, Inc. (FOLD) Stock Analysis: Navigating the Biotech Sector with a 23.7% Revenue Growth - DirectorsTalk Interviews

Mar 03, 2026

Mar 02, 2026

Bradley Campbell sells 75,000 FOLD shares under 10b5-1 plan (FOLD) - Stock Titan

Mar 02, 2026

Mar 02, 2026

Vanguard Group Inc. Buys 126,441 Shares of Amicus Therapeutics, Inc. $FOLD - MarketBeat

Mar 02, 2026